See also this year's filing and all EDGAR filings for this company.
PDF Report 0001124105_2020_GYRE_Therapeutics_INC.pdf
Logs
Graph
Absolute values for 0001124105, GYRE Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 96,066,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 304,000 |
| 3 | remainder_Assets | 2,184,000 |
| 4 | LiabilitiesCurrent | 28,899,000 |
| 5 | LiabilitiesNoncurrent | 1,319,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 13,558,310 |
| 9 | ResearchAndDevelopmentExpense | 38,984,151 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 593 |
| 12 | remainder_NetIncome | 2,774,169 |
| 13 | remainder_ComprehensiveNetIncome | 24,386 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 98,554,000 |
| 1 | Liabilities | 30,218,000 |
| 2 | Expenses | 52,542,461 |
| 3 | Revenues | 593 |
| 4 | StockholdersEquity | 68,336,000 |
| 5 | NetIncome | -49,767,699 |
| 6 | ComprehensiveNetIncome | -49,755,506 |
| 7 | BaseVar | 92,056,804 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.54 |
| 9 | EconomicCapitalRatio | 2.71 |
Edgar->Model Mapping
Feature Distribution
Change over Time
